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<0.5 @l. CC timeswere similar. No pt had perioperative Ml by ECG criteria.
In the HIGH grp LV stroke work index was reduced at 0.5 and 1 hr (18 + 2.0,
21 + 2.3vs29 +3.9 g.n’dmzp < 0.05) vspreCC. In the LOW grp LVSWIwas
unchanged vs pre CC up to 3 hrs. By 3 hrs LVSWIwas significantly higher in
the LOW grp (28.1 + 2.5 vs 21.9 + 1.9 g.nVm2,p < 0.05) vs HIGH grp. Peak
rate of pressure rise +dP/dt did not change in either grp but -dP/dt increased
at 3 hrs in LOW grp (942 + 57 vs 726 +37 mmH@ p < 0.05) vs pre CC.
conclusion: The release kinetics of TnT differ from those of CK with greater
TnT release. Prolonged TnT but not CK release predicts delayed recovety
of global LV function. The more sustained release of TnT may be related to
greater myocardial damage reflected by releaae of myofibril bound TnT.
1931-81] ~~~ea~edlncidence of~~o~ein~t~ial ~i~~illati~n
Patients After a MAZE Procedure
S.L. Kopacky, H.V. Schaff, S.C. Hammill, T. Cragun, J.A. Dearani,
K.R. Bailey. Mayo Clinic, Rocheatec MN, USA
The MAZE procedure decreases the incidence of atrial fibdllation, but its
subsequent effect on stroke is not clear. We report”the resulta of MAZE
procedure performed on66patients with atrialfibrillation atasingleinstitutiom
Forty-five patienta were male and 21 were female with the avarage age
of 61 years at the time of surgery. The primay indication for surgery is
ae follows: atrial fibrillation -30 patients, atrial fibrillation and CABG -3
patients, valve repair -26 patiente and ASD -4 patients. The average
duration of post-op follow-up is 306 days. Twenty-nine of the 66 patients had
high rick criteria for stroke (prior stroke 7, history OfCHF 12, hypertension
6, and decreased left ventricular function pa.t-op 10) as determined by the
Stroke Prevention in Atrial Fibrillation Study. Postoperatively,9 patients were
treated with chronic antimagulants and the remainder were treated with
aspirin therapy. Ten patients had recurrence of atnal fibrillation after hospital
discharge. No patients had a stroke or transient iachemic attack during the
follow-up period (upper 95% confidence limit on the rate of events = 5.4
events per 100 patient years).
Conclusions: Even in high risk patients for stroke, the MAZE procedure
appears effective in reducing the incidence of subsequent stroke in patients
with atrial fibrillation.
1931-821 QualitY Of Life f%bvhgTransfnYo~a~dial
Revaecularizstion Ueing The Heart La~r:
Randomized Study Reaulta
S.W. Boyce, R.H. Cooke, S. Aranki, L.H. Cohn, D.A. Cooley, J. Crew,
G. Fontana, O.H. Frazier, B. Griffith, K.P.Lendolfo, A.M. Lansing, J.E. Lowe,
B.W. Lytle, R.J. March, M. Mirhoseini, C.R. Smith. Washington /-foapita/
Centec Washington, DC, USA, TMR-CC2 Investigational Centars, USA
One hundred aixty patients (61 + 11yrs., 19% F) with Canadian Hearl Asso-
ciation Clasaificstion III-IV angina, who were not candidates for conventional
CABGVPTCArevascularization, were enrolled in a randomized clinical study
comparing Transmyocardial Revascularization (TMR) using the PLC COZ
laser system (77 pts.) to medical therapy (63 pts.). PMH: CABG 88%; PTCA
50yO;AMI 78%: CHF36%. Quality of life was meaaured with the SF-36 and
the Seattle Angina Questionnaire (SAQ)attimeof enrollment, and at3, 6, and
12 months. lnTMR patients, the SF-36 suwey revealed an improvement from
16% to 46% in standard physical health status and standard mental health
statue compared with baseline. In contrast the medical management patients
experienced a change of –13% to +13% over the same time period. The
average quality of life index as measured by the SAQ (the sum of exertional
capacity, anginal stability, anginal frequency, treatment satisfaction, and dis-
ease perception) increased +127Y. on TMR, while it remained unchanged
(+1%) in the control arm. These data demonstrate a marked improvement
in quality of life, as measure by self administered questionnaires, in patients
treated with TMR versus thoee continued on medical management.
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Survival in Infancy: Strategies to Regulate
Pulmonary Resistance
M.M.Boucak, B. Pietra, E. Shafer, H.M. Sondheimer, D.D. IVY,M. Luna,
K. Schneider, P.Hall, O. Campbell. The University of Co/oradfl/re
Children’s Hospital, Danvar, CO, USA
The risk of death for infants enrolled in a transplant (tx) protocol is greateat
while awaiting a donor organ followed by the risk of dying early post-tx. The
purpose of this study was to evaluate two strategies to manipulate pulmonary
resistance and their impact on overall mortality; 1) increase pulmonary resis-
tance to maintain hemodynamic stability pre-tx and 2) decrease pulmona~
resistance to avoid donor right heart failure post-fx. 23 infants (<6 month
at listing) were listed at 1,1 + 1 month from 4/94-6/96. Hypoplastic left
heart eyndrome (HLHS) and variants was the diagnosis leading to listing
in 16 infants (70%). The remainder (7) had complex congenital heari dis-
ease, including pulmonary atresia with RV dependent corona~ circulation
in 3 infants, and single ventricle in 2 infante. 19/23 (83%) received PGE
while waiting, 16/23 continuously. Waiting time was 52 +37 days. Strategies
to increase pulmonary resistan~e were used in 20/23 (87%), including 1)
supplemental inhaled nitrogen (SIN) in 13 (FiOz 16-20%), 2) maintaining
a restrictive atrial communication in 6, and 3) pulmonaty artery band in 3.
Waiting infants grew 24 + 18 grams/day and were intubated only 7 + 6
days. Waiting mortality was 4% (1/23 an infant poet open heart surgery). 20
infants have undergone transplant and all received intravenous pulmonary
vascdilators. 2 remain listad. Inhaled nitric oxide (INO) (2-20 PPM) was used
in 75% of infants with pulmonary hypertension pre-fx. INO was continued for
a mean of 5 days (range 1-17 days). Post tx survival was 90% (16/20) at
1.2 + 0.8 years. The pulmona~ artery pressure wae 20.6 + 4.7 mmHg and
wedge pressure was 7.9 + 4.7 mmHg at 1 year.
These data indicate that strategies to raise pulmonary resistance (SIN,
etc.) pre-fx can contribute to improved suwival and the rick of pulmonary
hypertension and graft failure post fx can be controlled with INO. There was
a 94?4survival rate while listed and 90Y0sunfived tx, thus the overd (pre
and post) survival was 870/..
1932-651 Heat’tTransplantetiOn in Cflildrenv#ith Visceral
Heterotsxy and Complex Congenital Heart Disease
R. Larsen, J. Eguchi, L. VanderOussen, N. Mulla, G. Shirali, M. Kuhn,
R. Chinnock, A. Razzouk, S. Gundty, L. Bailey. I_onraLinda University
Children’s Hospitsl, Loma Linda, CA, USA
Visceral heterotsxy (VH) ie frequently associated with complex congenital
heart disease, dextrocsrdia, situs inversus, and abnormal venous connat-
ions. Surgical mortality and mohidity in these children is high. Pts are
frequently poor candidates for Fontan operation becauee of AV valve insuffi-
ciency,ventricular dysfunction, and/or elevated PVR. Purpose: To determine
the rates of suwival, rejection, infection, and ra-operation after cardiac trans-
plantation (tx) in pts with VH. Population.’ We reviewed the records on the
30 pts with VH who have undergone tx at our institution since 1989. Twenty
had undergone previous cardiac operations. Median age at tx was 2.7 yre
(range: 1 week-17.7 yrs). Twenty pts had asplenia; 10 polysplenia. Fifteen
pts had dextrocardia, 13 atrial situs inversus, 18 bilateral SVC, 7 interruptad
IVC, 13TAPVC, and 6 PAPVC. Median PAp before tx was 19 mm Hg (range:
11-34). Follow-up since tx was 4.1 + 1.2 yrs. Resu/ts: Suwival at 30 days, 1
yr, 3 yra, and 5 yrs was 93Y0,64%, 74%, and 65%, respectively. Causes of
death included graft failure (l), rejection (3), sepsis (2), pulmonary venous
obstruction (l), Iymphoproliferative disease (l), and tx coronary disease (l).
Splenic status, dextrocardia, age at Tx, previoue procedures, mean PAP,
situs, venous anomalies were not independent fisk factors for death. Rates
of rejection and infection after fx were not different than age-matched tx pts
without VH. Two pts required re-operation for pulmona~ venous stenosea; 1
required dilatation of SVC obstruction. Conclusion.’Despite complex anoma-
lies of situs and great veseel arrangements, innovative surgical techniques
have enabled good suwival following fx for pts with VH. Cardiac M should be
considered for primary and “rescue” therapy for children with VH who are at
high risk for more conventional surgery.
